Epidermal barrier abnormalities in exfoliative ichthyosis with a novel homozygous loss‐of‐function mutation in CSTA

Autosomal recessive exfoliative ichthyosis (AREI) results from mutations in CSTA, encoding cysteine protease inhibitor A (cystatin A). We present a 25‐year‐old man from Iran with consanguineous parents, who presented with congenital erythroderma, hyperhidrosis and diffuse hyperkeratosis with coarse palmoplantar peeling of the skin, aggravated by exposure to water and by occlusion. Candidate gene analysis revealed a previously unknown homozygous loss‐of‐function mutation c.172C>T (p.Arg58Ter) in CSTA, and immunostaining showed absence of epidermal cystatin A, confirming the diagnosis of AREI. Ultrastructural analysis by transmission electron microscopy showed normal degradation of corneodesmosomes, mild intercellular oedema in the spinous layer but not in the basal layer, normal‐appearing desmosomes, and prominent keratin filaments within basal keratinocytes. Thickness of cornified envelopes was reduced, lamellar lipid bilayers were disturbed, lamellar body secretion occurred prematurely and processing of secreted lamellar body contents was delayed. These barrier abnormalities were reminiscent of (albeit less severe than in) Netherton syndrome, which results from a deficiency of the serine protease inhibitor LEKTI. This work describes ultrastructural findings with evidence of epidermal barrier abnormalities in AREI.

[1]  M. Simpson,et al.  Acral Peeling Skin Syndrome Resulting from a Homozygous Nonsense Mutation in the CSTA Gene Encoding Cystatin A , 2013, Pediatric dermatology.

[2]  A. Hovnanian Netherton syndrome: skin inflammation and allergy by loss of protease inhibition , 2013, Cell and Tissue Research.

[3]  D. Kelsell,et al.  Cell–cell connectivity: desmosomes and disease , 2012, The Journal of pathology.

[4]  D. Kelsell,et al.  Mutations in CSTA, encoding Cystatin A, underlie exfoliative ichthyosis and reveal a role for this protease inhibitor in cell-cell adhesion. , 2011, American journal of human genetics.

[5]  R. Tazi-Ahnini,et al.  A nonsynonymous substitution of cystatin A, a cysteine protease inhibitor of house dust mite protease, leads to decreased mRNA stability and shows a significant association with atopic dermatitis , 2007, Allergy.

[6]  P. Elias,et al.  Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome. , 2006, The Journal of investigative dermatology.

[7]  K. Mitsuishi,et al.  Cystatin A inhibits IL-8 production by keratinocytes stimulated with Der p 1 and Der f 1: biochemical skin barrier against mite cysteine proteases. , 2005, The Journal of allergy and clinical immunology.

[8]  J. Kos,et al.  Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  P. Elias,et al.  Altered lamellar body secretion and stratum corneum membrane structure in Netherton syndrome: differentiation from other infantile erythrodermas and pathogenic implications. , 1999, Archives of dermatology.

[10]  A. Steven,et al.  Protein composition of cornified cell envelopes of epidermal keratinocytes. , 1994, Journal of cell science.